Author Archives: superadmin-pantaipremier

End TB, Save lives

End TB, Save lives

Persistent cough that lasts for more than 3 weeks with the presence of blood or mucus is a warning sign for a deadliest infectious disease known as Tuberculosis (TB).1, 2 TB bacteria spreads through air when someone with TB disease talks, coughs or sneezes.3 Individuals at risk for TB are those living with HIV and have close contact with TB patients and other at-risk groups such as patients undergoing dialysis, anti-TNF (tumor necrosis factor) treatment and patients preparing for an organ transplant.3 These individuals have weakened immune system which makes them vulnerable to getting infected.

Individuals with latent TB infection have TB bacteria in their bodies but are not sick, do not display symptoms or cannot spread the bacteria to others because the bacteria are not active. However, these individuals may develop TB disease in the future, hence, they are often prescribed treatment to prevent from developing TB disease. Whereas, individuals with TB disease are sick from TB bacteria that are active, multiplying and destroying tissues in their body. These individuals usually display symptoms of the TB disease and are able to spread the bacteria to others.6

TB is a preventable and curable disease, however, a person with TB can die if they do not get treatment on time.5, 6 Most TB cases are reported to progress from latent TB infection (LTBI) rather than local transmission, especially in those whose immune systems are weakened. Hence, the transmission of the infectious TB can be prevented through prompt case finding and treatment of LTBI as a crucial strategy to achieve the elimination of TB.7, 8, 9

At Pantai Premier Pathology, we provide tests for Tuberculosis (TB):

  1. TB Serology Rapid Test
  2. MYCOBACTERIUM TB DNA PCR (FFPE TISSUE)
  3. MYCOBACTERIUM TB DNA PCR
  4. Mycobacterium TB Rifampin Resistance
  5. Mycobacterium Culture
  6. Mycobacterium Identification
  7. Mycobacterium Sensitivity

For more information on the tests provided, please contact us at +603-42809115 (Customer Service) or email us at info@premierpathology.com.my.

 

Reference

1- Signs & Symptoms. (n.d.). Centers for Disease Control and Prevention: Division of Tuberculosis Elimination. Retrieved March 8, 2021, from https://www.cdc.gov/tb/topic/basics/signsandsymptoms.htm

2- Tuberculosis (TB). (n.d.). NHS. Retrieved March 8, 2021, from https://www.nhs.uk/conditions/tuberculosis-tb/

3- How to Protect Ourselves from TB. (n.d.). World Health Organization. Retrieved March 11, 2021, from https://cdn.who.int/media/docs/default-source/campaigns-and-initiatives/world-tb-day-2020/how-to-protect-ourselves-from-tb.pdf?sfvrsn=ba76911a_2

4- Tuberculosis: General Information What is TB? (n.d.). Centers for Disease Control and Prevention: Division of Tuberculosis Elimination. Retrieved March 11, 2021, from https://www.cdc.gov/tb/publications/factsheets/general/tb.htm

5- Tuberculosis (TB). (n.d.-b). Centers for Disease Control and Prevention. Retrieved March 8, 2021, from https://www.cdc.gov/tb/publications/factsheets/general/tb.htm

6 – World Tuberculosis Day 2021: THE CLOCK IS TICKING. (n.d.). World Health Organization. Retrieved March 10, 2021, from https://www.who.int/campaigns/world-tb-day/world-tb-day-2021

7- Latent TB Infection and TB Disease. (2016). Centers for Disease Control and Prevention. https://www.cdc.gov/tb/topic/basics/tbinfectiondisease.htm

8- Lönnroth, K., Migliori, G. B., Abubakar, I., D’Ambrosio, L., De Vries, G., Diel, R., … & Ochoa, E. R. G. (2015). Towards tuberculosis elimination: an action framework for low-incidence countries. European Respiratory Journal, 45(4), 928-952.

9- Dobler, C. C., Martin, A., & Marks, G. B. (2015). Benefit of treatment of latent tuberculosis infection in individual patients. European Respiratory Journal, 46(5), 1397-1406.

 

 

Preventing the transmission of Covid-19 with proper testing and vaccination

Preventing the transmission of Covid-19 with proper testing and vaccination

It has been more than a year since we have been battling against the COVID-19 pandemic. The World Health Organization declared the rapidly spreading coronavirus outbreak a pandemic on 11 March 2020, acknowledging the spread of the virus to all countries across the globe.1 This has become an alarming situation as the number of daily cases increased significantly.

 

As part of the effort to respond to the COVID-19 pandemic, health screening tests for Covid19 were implemented to identify Covid19 positive cases and to ensure the safety of the people at large. This measure was taken to contain the spread of the virus and to prevent further disease transmission.2 The common Covid-19 tests include RT-PCR Covid19 test and rapid Covid-19 test.

 

The RT-PCR Covid19 test is usually analyzed in a lab. The rapid Covid19 test on the other hand includes the rapid PCR test and Covid antigen test. For rapid PCR test, the sample can be analyzed at the point-of-care, such as at the clinic itself. Antigen tests are often simpler and may provide results quicker than other molecular tests. Although antigen tests can be less accurate and may need additional diagnostic confirmation tests, they can be made more widely available because they are easy and simple.

 

Which Covid-19 test do you need? 4, 5

 

Other efforts to respond to the COVID-19 pandemic is the race to develop and deploy safe and effective vaccines. Vaccines save lives by training and gearing up the body’s natural defence system (immune system) to distinguish and fight off viruses and bacteria. The body will be ready to immediately destroy any disease-causing germs they encounter later once they get exposed to them.6

Figure 1. How do vaccines work?7

(link for image: https://www.immunology.org/celebrate-vaccines/public-engagement/guide-childhood-vaccinations/how-vaccines-work)

Equitable access and distribution of the Covid-19 vaccine will be facilitated to protect the people, with people most at risk prioritized. While the work towards deploying a safe and effective vaccine is under going, it is important to protect yourself and others from infection by washing your hands or using hand sanitizers frequently.1, 6

 

At Pantai Premier Pathology, we provide Covid-19 tests:

COVID-19 TEST TEST CODE
Covid RT-PCR Test COVID19
Covid Rapid PCR Test (FilmArray) FACOVID
Covid Antigen Test COVIDAG
Covid Antibody Test COVIDAB
FilmArray Respiratory Panel 2.1 Plus FARP3P

 

For more information on the tests provided, please contact us at +603-42809115 (Customer Service) or email us at info@premierpathology.com.my

 

 

Reference

1- Archived: WHO Timeline – COVID-19. (2020, April 27). World Health Organization. https://www.who.int/news/item/27-04-2020-who-timeline—covid-19

2- Shah, A. U. M., Safri, S. N. A., Thevadas, R., Noordin, N. K., Abd Rahman, A., Sekawi, Z., … & Sultan, M. T. H. (2020). COVID-19 outbreak in Malaysia: Actions taken by the Malaysian government. International Journal of Infectious Diseases, 97, 108-116.

3- Coronavirus Disease 2019 Testing Basics. (n.d.). U.S. Food and Drug Administration (FDA). Retrieved January 27, 2021, from https://www.fda.gov/consumers/consumer-updates/coronavirus-disease-2019-testing-basics

4- COVID-19: contact tracing. (n.d.). World Health Organization. Retrieved February 1, 2021, from https://www.who.int/westernpacific/emergencies/covid-19/information/covid-19-testing

5- Antibody (Serology) Testing for COVID-19: Information for Patients and Consumers. (n.d.). U.S. Food and Drug Administration (FDA). Retrieved February 1, 2021, from https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/antibody-serology-testing-covid-19-information-patients-and-consumers

6- COVID-19 vaccines. (n.d.). World Health Organization. Retrieved February 1, 2021, from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines

7- How vaccines work. (n.d.). British Society for Immunology. Retrieved February 3, 2021, from https://www.immunology.org/celebrate-vaccines/public-engagement/guide-childhood-vaccinations/how-vaccines-work

Exclusive CME webinar on LIVERFASt

How LIVERFASt can assist you in assessing liver functions in patients at high metabolic (diabetic or obese) risk?

This event is co-organised by Pantai Premier Pathology and Fibronostics.

Dear Dr,

Register now and learn how LIVERFASt can assist you in assessing liver functions in patients at high metabolic (diabetic or obese) risk on Thursday 25th February.

After registration, you will receive a confirmation email containing information and link for joining the webinar.

Thank you and have a good day.

 

FEATURED SPEAKERS

  • Dr Mona MUNTEANU, MD, PhD | Chief Scientific Officer at Fibronostics
  • Dr Ronald QUIAMBAO, MD | Chief Medical Officer at Fibronostics
Event Details
Date:

25th February 2021, Thursday

Time:

12: 00 PM – 2:00 PM (Malaysia Time)

 Program:

12:00 PM  Introductions

12:10 PM  Presentation

1:40 PM    Q&A

2:00 PM    End of webinar

What Do You Need to Know About Colorectal Cancer?

What do you need to know about Colorectal Cancer?

Colorectal cancer, also called colon cancer, occurs in the colon or rectum.1 In Malaysia, colorectal cancer is the second most common cancer in male and third most common cancer in females. The mortality rate due to this cancer is increasing and it holds the fourth place in causing cancer death globally.2, 3, 4

The colon is the large intestine or large bowel, whereas, the rectum is the passageway that connects the colon to the anus.1, 5 Abnormal growth, known as polyps, sometimes forms in the colon or rectum. Overtime, some polyps eventually may become cancerous and form a tumour on the rectum or colon wall and subsequently grow into blood vessels or lymph vessels which increases the metastasis rate to other anatomical sites.1, 5, 6, 7 

Most cancers of the colorectal region are classified as adenocarcinomas (the mucus producing glands lining the colon and rectum). Other less common colorectal cancers are carcinoid tumours (which forms in intestinal cells that produce hormones), gastrointestinal stromal tumours (which forms in specialised colonic cells), lymphomas (immune system cancers that forms in the colorectal region) and sarcomas (which forms in the blood vessels or occasionally on colorectal walls).  5, 6, 7

Colorectal polyps and cancer do not always cause symptoms upon onset. When symptoms occur, they may include stomach pain or cramps that persist, blood in stool, sudden loss of weight with no known explanation, constant fatigue, diarrhea, constipation and stomach bloating.7, 8

Some common factors that increase the risk of colorectal cancer are obesity, aging, smoking, sedentary lifestyle, alcohol consumption, tobacco smoking, westernized diet (high-calorie, high meat, fat-rich and fibre-deficient diet), high levels of insulin in blood, gastrointestinal inflammation and hyperinsulinemia.3, 4, 7, 9, 10, 11

Screening regularly to detect polyps at an early stage, especially when it is asymptomatic is important to prevent them from turning into cancer or to detect cancer early in order to start treatment when it works best.1

 

At Pantai Premier Pathology, we provide screening tests related to Colorectal Cancer. Here are some tests related to colorectal cancer offered by Pantai Premier Pathology:

 

  1. Fecal Occult Blood Test (FOBT)
  2. Tumour marker – CEA Test (Carcinoembryonic Antigen)

 

For more information on the tests provided, please contact us at +603-42809115 (Customer Service) or email us at info@premierpathology.com.my.

 

 

References:

  1. What is Colorectal Cancer? (n.d.). Centers for Disease Control and Prevention. Retrieved October 8, 2020, from https://www.cdc.gov/cancer/colorectal/basic_info/what-is-colorectal-cancer.htm
  2. Veettil, S. K., Lim, K. G., Chaiyakunapruk, N., Ching, S. M., & Hassan, M. R. A. (2017). Colorectal cancer in Malaysia: Its burden and implications for a multiethnic country. Asian journal of surgery, 40(6), 481-489.
  3. GLOBOCAN 2018. (2018, September 12). UICC, Global Cancer Control. https://www.uicc.org/news/new-global-cancer-data-globocan-2018#:~:text=GLOBOCAN%202018%20is%20an%20online,for%20all%20cancer%20sites%20combined.
  4. Ministry of Health Malaysia. (2019). Malaysia National Cancer Registry 2012- 2016 (5). Retrieved from https://drive.google.com/file/d/1BuPWrb05N2Jez6sEP8VM5r6JtJtlPN5W/view
  5. Marley, A. R., & Nan, H. (2016). Epidemiology of colorectal cancer. International journal of molecular epidemiology and genetics, 7(3), 105–114.
  6. What is Colorectal Cancer?. (n.d.). American Cancer Society. Retrieved October 9, 2020, from https://www.cancer.org/cancer/colon-rectal-cancer/about/what-is-colorectal-cancer.html
  7. Colorectal Cancer: Introduction. (2019). American Society of Clinical Oncology (ASCO). Retrieved October 13, 2020, from https://www.cancer.net/cancer-types/colorectal-cancer/introduction
  8. What Are the Symptoms of Colorectal Cancer? (n.d.). Centers for Disease Control and Prevention. Retrieved October 14, 2020, from https://www.cdc.gov/cancer/colorectal/basic_info/symptoms.htm
  9. Sung, J. J. Y., Ng, S. C., Chan, F. K. L., Chiu, H. M., Kim, H. S., Matsuda, T., … & Reddy, N. (2015). An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut, 64(1), 121-132.
  10. Center, M. M., Jemal, A., Smith, R. A., & Ward, E. (2009). Worldwide variations in colorectal cancer. CA: a cancer journal for clinicians, 59(6), 366-378.
  11. What Are the Risk Factors for Colorectal Cancer? (n.d.). Centers for Disease Control and Prevention. Retrieved October 14, 2020, from https://www.cdc.gov/cancer/colorectal/basic_info/risk_factors.htm

Molecular Oncology services provided by Pantai Premier Pathology

Molecular Oncology services provided by Pantai Premier Pathology

Premier Integrated Labs has distinguished itself as a leader in molecular oncology by the breadth and depth of service to support pathologists and oncologists in making diagnoses, assessing prognoses, and discovering opportunities for targeted therapy & other treatment option as per suggested in NCCN Guidelines and other reputable oncology organizations.

 

Molecular oncology service in PPP comprises of single gene assays, multi-gene panels and comprehensive genomic profiling. With testing methods like FISH, IHC, PCR, and NGS are available in-house. With this comprehensive range of tests, accompanied with the clarity and personalization of the consultations, it allows an integrated approach to the case, maximizes yield from small specimens, and minimizes turnaround time.

 

Our single genes molecular testing is to help physician in deciding fast and actionable treatment options, like BRCA 1 & 2 for Olaparib chemotherapy on breast, ovarian and prostate cancer. Same goes to PDL-1 sp142 testing for breast cancer immunotherapy treatment.

 

Besides single genes testing, PPP have come-up with our own actionable panel testing, which comprises of biomarkers that have treatment suggestion which is most commonly requested by physicians. For example, Lung Cancer Panel which consist of EGFR, ALK, ROS1, KRAS, BRAF, and PDL1.

 

Besides solid tumour molecular testing, PPP also offers a broad collection of comprehensive, targeted and single gene liquid biopsy assays for solid tumor cancer like T790M for Lung Cancer and hematologic malignancies. Our goal is to provide all patients access to testing in a timely manner to ensure efficient diagnosis and disease progression monitoring.

 

Next-Generation Sequencing (NGS) & Advancing Precision Oncology in PPP

While it began as a revolutionary research tool a decade ago, NGS is now the method of choice for simultaneous genomic profiling of multiple cancer markers.  For hospitals, the advantages of NGS over traditional methods are indisputable in terms of time savings, tissue perservation, and a precision oncology approach to patient care.

 

Comprehensive Genomic Profiling (CGP)

Our pan-cancer analysis using next-generation sequencing assay includes 523 genes involved in solid tumor development and progression. This panel provides broad coverage of actionable markers supported by clinical guidelines and on-going clinical trials.

Biomarkers detected are implicated in a variety of tumor types including bladder, brain/CNS, breast, cervical, colorectal, endometrial, esophageal, gastric, head and neck, kidney, liver, lung, melanoma, ovarian, pancreatic, prostate, stomach, and thyroid.

Clinical applications of our CGP NGS:

  • Identifying targetable alterations to guide treatment decision
  • Monitoring disease status
  • Detecting potential resistance to therapy and its cause